Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 30, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

February 28, 2025

Conditions
Gastroesophageal Reflux Disease (GERD)Laryngopharyngeal Reflux (LPR)Reflux Disease, Gastro-EsophagealMotility Disorder
Interventions
DEVICE

Transoral Incisionless Fundoplication

Transoral incisionless fundoplication (TIF) is a minimally invasive, endoscopic fundoplication technique. Transoral Incisionless Fundoplication (TIF) is an FDA approved endoluminal fundoplication technique which utilizes EsophyX device to restore the valve at the gastroesophageal junction. The EsophyX device (EndoGastric Solutions, Redmond, Wash, USA) is an FDA approved procedure for chronic of refractory GERD.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

EndoGastric Solutions

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT05579587 - Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients | Biotech Hunter | Biotech Hunter